Blood-Based Biomarkers of Alzheimer's Disease: Challenging but Feasible

Thambisetty, Madhav, Lovestone, Simon·2010·Biomarkers in Medicine

Cited by (185)

Items 101–185 of 185

  1. Paper-Based Detection Device for Alzheimer’s Disease—Detecting β-amyloid Peptides (1–42) in Human Plasma
    Wei-Hsuan Sung, Jung‐Tung Hung, Ya-Jui Lin, Chao‐Min Cheng · 2020 · Diagnostics
  2. The Potential of Pathological Protein Fragmentation in Blood-Based Biomarker Development for Dementia – With Emphasis on Alzheimer’s Disease
    Dilek Inekci, Ditte Svendsen Jonesco, Sophie Kennard, M.A. Karsdal, Kim Henriksen · 2015 · Frontiers in Neurology
  3. Plasma contact factors as novel biomarkers for diagnosing Alzheimer’s disease
    Jung Eun Park, Do Sung Lim, Yeong Hee Cho, Kyu Yeong Choi, Jang Jae Lee, Byeong Chae Kim, Jung Sup Lee, Jung Sup Lee · 2021 · Biomarker Research
  4. Blood biomarkers for Alzheimer’s disease
    Simon Lovestone · 2014 · Genome Medicine
  5. Blood-based gene-expression biomarkers identification for the non-invasive diagnosis of Parkinson’s disease using two-layer hybrid feature selection
    Jisha Augustine, A. S. Jereesh · 2022 · Gene
  6. Biomarkers of Alzheimer's disease: The present and the future
    Sylvain Lehmann, Constance Delaby, Jacques Touchon, Christophe Hirtz, Audrey Gabelle · 2013 · Revue Neurologique
  7. Is there a role for small molecule metabolite biomarkers in the development of a diagnostic test for endometriosis?
    Nicola E. Tomkins, Jane E. Girling, Berin A. Boughton, Sarah J. Holdsworth‐Carson · 2022 · Systems Biology in Reproductive Medicine
  8. Progress Towards a Consensus on Biomarkers for Alzheimer‘S Disease: A Review of Peripheral Analytes
    Alan Rembach, Tim M. Ryan, Blaine Russell Roberts, James D. Doecke, W.J. Wilson, Andrew D. Watt, Kevin Jeffrey Barnham, Colin Louis Masters · 2013 · Biomarkers in Medicine
  9. Alzheimer's Disease Diagnosis Using Misfolding Proteins in Blood
    HeeYang Lee, Daniella A. Ugay, Seungpyo Hong, Young Soo Kim · 2020 · Dementia and Neurocognitive Disorders
  10. Metabolomics in Alzheimer's disease research
    Clara Ibáñez, Carolina Simó, Alejandro Cifuentes · 2013 · Electrophoresis
  11. Is liquid biopsy mature enough for the diagnosis of Alzheimer’s disease?
    Xun Gong, Hantao Zhang, Xiaoyan Liu, Yi Liu, Junlin Liu, Funmilayo Omotoyosi Fapohunda, Peng Lü, Kun Wang, Min Tang · 2022 · Frontiers in Aging Neuroscience
  12. Identification of circulating risk biomarkers for cognitive decline in a large community‐based population in Chongqing China
    Yu Kang, Zijuan Feng, Qian Zhang, Mingjing Liu, Yanhua Li, Huan Yang, Lingling Zheng, Chunjiang Cheng, Weitao Zhou, Dandan Lou et al. · 2024 · Alzheimer s & Dementia
  13. Evolving Relevance of Neuroproteomics in Alzheimer’s Disease
    Simone Lista, Henrik Zetterberg, Sid E. O’Bryant, Kaj Blennow, Harald Juergen Hampel · 2017 · Methods in molecular biology
  14. Carbon Nanostructure-Based Materials: A Novel Tool for Detection of Alzheimer’s Disease
    Mohammad Ashfaq, Neetu Talreja, Divya Chuahan, Werayut Srituravanich · 2019 · Springer eBooks
  15. Biological determinants of blood-based biomarker levels in Alzheimer’s disease: role of nutrition, inflammation, and metabolic factors
    Aparna Inamdar, Parashuram Bugadannavar, Mahesh Shivabasappa Palled, Savita Umarani, Preeti S. Salve, Bannimath Gurupadayya, Priyanka Deelip Patil, Himanshu Sharma · 2025 · Frontiers in Aging Neuroscience
  16. Working Towards a Blood-Derived Gene Expression Biomarker Specific for Alzheimer’s Disease
    Hamel Patel, Raquel Iniesta, Daniel R. Stahl, Richard Dobson, Stephen Newhouse · 2020 · Journal of Alzheimer s Disease
  17. Identify biological Alzheimer’s disease using a novel nucleic acid–linked protein immunoassay
    Yi‐Ting Wang, Nicholas James Ashton, Joseph Therriault, Andréa Lessa Benedet, Arthur C. Macedo, Ilaria Pola, Étienne Aumont, Guglielmo Di Molfetta, Jaime Fernández Arias, Kübra Tan et al. · 2024 · Brain Communications
  18. Neurodegeneration, β‐amyloid and mood disorders: state of the art and future perspectives
    Armando Piccinni, Nicola Origlia, Antonello Veltri, Chiara Vizzaccaro, Donatella Marazziti, Federica Vanelli, Ilenia Moroni, Luciano Domenici, Liliana Dell’Osso · 2012 · International Journal of Geriatric Psychiatry
  19. Polymer-Based Electrochemical Sensors for the Diagnosis of Neurodegenerative Diseases
    Qitong Zhang, Guangran Zhao, Shilin Wang, Yuxuan Song, Yuanzheng Sun · 2025 · Cellular and Molecular Neurobiology
  20. Circulating levels of vascular endothelial growth factor in patients with Alzheimer’s disease: A case-control study
    Thays Martins Vital da Silva, Angélica Miki Stein, Flávia Gomes de Melo Coelho, André Veloso Lima Rueda, Rosana Camarini, Ruth Ferreira Galduróz · 2022 · Behavioural Brain Research
  21. Toenail as Non-invasive Biomarker in Metal Toxicity Measurement of Welding Fumes Exposure - A Review
    Siti Farhana Zainal Bakri, Azian Hariri, N F Ma’arop, N S A W Hussin · 2017 · IOP Conference Series Materials Science and Engineering
  22. Will Posttranslational Modifications of Brain Proteins Provide Novel Serological Markers for Dementias?
    Yong Wang, Mette Grøndahl Sørensen, Q. Zheng, C. Zhang, M.A. Karsdal, Kim Henriksen · 2012 · International Journal of Alzheimer s Disease
  23. Serum Potassium Is Associated with Cognitive Decline in Patients with Lewy Body Dementia
    Lasse Melvaer Giil, Stein-Erik Hafstad Solvang, Malin Melvaer Giil, Kristoffer H. Hellton, Ragnhild Eide Skogseth, Audun Osland Vik‐Mo, Tibor Hortobágyi, Dag Aarsland, Jan Erik Nordrehaug · 2019 · Journal of Alzheimer s Disease
  24. Development of a standardized flow cytometric method to conduct longitudinal analyses of intracellular CD3ζ expression in patients with head and neck cancer
    Deepak Upreti, Alok Pathak, Sam K. P. Kung · 2016 · Oncology Letters
  25. Blood SSR1: A Possible Biomarker for Early Prediction of Parkinson’s Disease
    Wen Zhang, Jiabing Shen, Yuhui Wang, Kefu Cai, Qi Zhang, Maohong Cao · 2022 · Frontiers in Molecular Neuroscience
  26. Innovations in the Assessment of Skeletal Muscle Health: A Glimpse into the Future
    Jonathan P. Beausejour, Kevan S. Knowles, Abigail T. Wilson, Lauren Colby Mangum, Ethan C. Hill, William J. Hanney, Adam J. Wells, David Hideyoshi Fukuda, JeffreyR. Stout, Matt S. Stock · 2024 · International Journal of Sports Medicine
  27. Microfluidic paper–based analytical extraction devices (µPAEDs): a cost-effective and portable solution for biomarkers, contaminants and VOC detection
    Shruti Janakiraman, Reshmi Saravana Bhava, Naresh Kumar Mani · 2025 · Microchimica Acta
  28. Proteomic Studies on the Development of the Central Nervous System and Beyond
    Chenggang Zhang · 2010 · Neurochemical Research
  29. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer’s Disease Risk
    Wayne Richard Leifert, Tori Nguyen, Alan Rembach, Ralph Nigel Martins, Stephanie Ruth Rainey‐Smith, Colin Louis Masters, David J. Ames, Christopher C. Rowe, S. Lance Macaulay, Maxime François et al. · 2015 · Journal of Alzheimer s Disease
  30. Plasma extracellular vesicle pathognomonic proteins as the biomarkers of the progression of Parkinson's disease
    Chien‐Tai Hong, Chen‐Chih Chung, Yi‐Chen Hsieh, Lung Chan · 2025 · BioScience Trends
  31. Alzheimer's Disease and the Quest for its Biological Measures
    Domenico Praticò · 2012 · Journal of Alzheimer s Disease
  32. Biomarkers will Revolutionize the way we Diagnose and Treat Alzheimer's Disease
    Alison Goate, David M. Holtzman · 2010 · Biomarkers in Medicine
  33. Fluid Biomarkers and APOE Status of Early Onset Alzheimer’s Disease Variants: A Systematic Review and Meta-Analysis
    Gurjeet Kaur, Anne Poljak, Nady Braidy, John D. Crawford, Jessica Lo, Perminder Singh Sachdev · 2020 · Journal of Alzheimer s Disease
  34. Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer’s Disease
    Giovanni Zuliani, Angelina Passaro, Cristina Bosi, Juana María Sanz, Alessandro Trentini, Carlo M. Bergamini, Davide Seripa, Antonio Greco, Monica Squerzanti, Roberta Rizzo et al. · 2018 · Disease Markers
  35. Potential of plasma inflammatory and angiogenic mediators for predicting spontaneous preterm delivery, intraamniotic infection/inflammation, and composite neonatal morbidity/mortality in women with early preterm premature rupture of membranes
    Hyeon Ji Kim, Kyo Hoon Park, Eunwook Joo, Min Jung Lee, Bo Young Choi · 2024 · American Journal of Reproductive Immunology
  36. Clinicopathological study of potential biomarkers of Plasmodium falciparum malaria severity and complications
    Nitin Bhardwaj, Md. Zohaib Ahmed, Supriya Sharma, Bina Srivastava, Veena Pande, Anupkumar R. Anvikar · 2019 · Infection Genetics and Evolution
  37. Repurposing of Kinase Inhibitors to Target c-Abl as Potential Therapeutics for Alzheimer’s Disease
    Qingzhang Zhu, Jianchun Chen, Xi Lawrence Wu, Xiaoping Jin, Bing Ruan · 2014 · Journal of Pharmaceutical Innovation
  38. Circulating Vesicular Biomarkers in Alzheimer’s Disease: From Mechanistic Insights to Clinical Applications
    Vinay Patil, Amit Sharma, Bhavin K Parekh, Renuka Jyothi.S, Priya Priyadarshini‐Nayak, Bethanney Janney-J, Gurjant Singh, Shaker Al-Hasnaawei, Manoj Kumar-Mishra · 2026 · Molecular Neurobiology
  39. Plasma acute phase proteins as potential predictors of intra-amniotic inflammation and infection in preterm premature rupture of membranes
    Hee Young Cho, Kyo Hoon Park, Eunji Oh, Min Jung Lee, Bo Young Choi, Eun Mi Im · 2024 · Innate Immunity
  40. Blood-Based DNA Methylation Marker Identification for Parkinson’s Disease Prediction
    Jisha Augustine, A. S. Jereesh · 2021 · Advances in intelligent systems and computing
  41. Serum Lipoprotein Profiling by NMR Spectroscopy Reveals Alterations in HDL-1 and HDL-2 Apo-A2 Subfractions in Alzheimer’s Disease
    Jonas Ellegaard Mortensen, Trygve Andreassen, Dorte Aalund Olsen, Karsten Vestergaard, Jonna Skov Madsen, Søren Risom Kristensen, Shona Pedersen · 2024 · International Journal of Molecular Sciences
  42. Recent Progress in the Identification of Non-Invasive Biomarkers to Support the Diagnosis of Alzheimer’s Disease in Clinical Practice and to Assist Human Clinical Trials
    Francois Bernier, Pavan Kumar, Yoshiaki Sato, Yoshiya Oda · 2015 · InTech eBooks
  43. Integrating Omic Technologies in Alzheimer’s Disease
    Antigoni Avramouli, Panagiotis Vlamos · 2017 · Advances in experimental medicine and biology
  44. Bioinformatics in the Identification of Novel Targets and Pathways in Neurodegenerative Diseases
    Jussi Paananen · 2017 · Current Genetic Medicine Reports
  45. The impact of genetic variability on Alzheimer’s therapies: obstacles for pharmacogenetic progress
    Ramón Cacabelos, Olaia A. Martínez-Iglesias, Natalia Cacabelos, Jairo Carrera, Daniel Rodríguez, Vinogran Naidoo · 2025 · Expert Opinion on Drug Metabolism & Toxicology
  46. Plasma Biomarkers in Alzheimer’s Disease
    Hitoshi Sohma, Yasuo Kokai · 2016 · InTech eBooks
  47. Genetic risk factor APOEε4 associates with plasma amyloid beta in amnestic mild cognitive impairment and alzheimer’s disease
    Rocksy Situmeang, Eka Julianta Wahjoepramono, Cahyono Kaelan, Jan Sudir Purba, Budhianto Suhadi, Suryani As’ád, Amiruddin Aliah, Ilham Jaya Patellongi, Syarifuddin Wahid · 2016 · Medical Journal of Indonesia
  48. A Software Solution for Preventing Alzheimer's Disease Based on MapReduce Framework
    Manal Zettam, Jalal Laassiri, Noureddine Enneya · 2017 · IEEE International Conference on Information Reuse and Integration (IRI)
  49. ML-based methods for detection of AD and MCI using blood biomarkers
    Hussam Daleel Shnawa Al-Kabi, Jamal Mustafa Al-Tuwaijari, Ali H. Husseen Al-Nuaimi · 2023 · AIP conference proceedings
  50. Plasma Kallistatin and Progranulin as Predictive Biomarkers of Intraamniotic Inflammation, Microbial Invasion of the Amniotic Cavity, and Composite Neonatal Morbidity/Mortality in Women With Preterm Premature Rupture of Membranes
    Kyo Hoon Park, Kyong‐No Lee, Iseop Cho, Min Jung Lee, Bo Young Choi, Da Eun Jeong · 2024 · American Journal of Reproductive Immunology
  51. Genome‐wide transcriptome analysis of Aβ deposition on PET in a Korean cohort
    Tamina Park, Jiyun Hwang, Shiwei Liu, Soumilee Chaudhuri, Sang Won Han, Dahyun Yi, Min Soo Byun, Yen-Ning Huang, Thea Jacobson Rosewood, Gijung Jung et al. · 2024 · Alzheimer s & Dementia
  52. Peripheral Blood Biomarkers for Endometriosis
    Amelie Fassbender, O Dorien, Christian Malte Becker, Thomas M. D’Hooghe · 2017 · Springer eBooks
  53. Cerebrospinal fluid biomarkers for neurodegenerative disorders
    Rita Margarida Almeida Santos Videira · 2013 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  54. THE INFLUENCE OF DEMENTIA CAREGIVER MENTAL HEALTH ON QUALITY OF CARE IN ARGENTINA
    Alejandra Morlett Paredes · 2014 · VCU Scholars Compass (Virginia Commonwealth University)
  55. A MapReduce-based Adjoint method for preventing brain disease
    Manal Zettam, Jalal Laassiri, Nourddine Enneya · 2018 · Journal Of Big Data
  56. Biomarkers and Risk Factors of Dementia
    Elisabeth M. C. Schrijvers · 2011 · RePub (Erasmus University Rotterdam)
  57. Lipidomic signatures reveal biomarkers of mild cognitive impairment
    Jayashankar Jayaprakash, Siddabasave Gowda B. Gowda, Divyavani Gowda, Hariom Yadav, Shalini Jain, Amanda Smith, Ambuj Kumar, Corinne A. Labyak, Michał M. Masternak, Peter J. Holland et al. · 2026 · Translational Psychiatry
  58. Biomarkers in Alzheimer's Disease and Lewy Body Disorders with Dementia
    Thomas Leyhe, Taher Darreh‐Shori, Christoph Laske, Michelle M. Mielke, Walter Maetzler · 2013 · International Journal of Alzheimer s Disease
  59. The Role of Adaptive and Innate Immunity in Alzheimer’s Disease
    Clive Holmes · 2021 · Cambridge University Press eBooks
  60. Glymphatic Efficiency is a Critical Factor for Using Abnormal Tau in Peripheral Tissues as Biomarker for Alzheimer’s Disease
    Ya‐Huan Lou · 2018 · Biomarkers and Applications
  61. Alzheimer’s Disease
    Jacques Fantini, Nouara Yahi · 2015 · Elsevier eBooks
  62. ARTÍCULO ORIGINAL: Determination of ApoE gene in patients with mild cognitive impairment
    Norbel Román, Carolina Boza-Calvo, Leonardo Calvo Flores, Alia Kozakova, Adriana Cortés, Luis Sequeira Rojas · 2014 · Revista Clínica Escuela de Medicina UCR-HSJD
  63. Shifting Our Focus to blood-based Biomarkers of Alzheimer’s Disease: the Promise of Ceramides and Sphingomyelins
    Michelle M. Mielke · 2012 · Neurodegenerative Disease Management
  64. Biomarkers in Alzheimer’s Disease: From Pathogenic Initiation to Downstream Outcomes
    Sun-Ho Han, Jong‐Chan Park, Inhee Mook‐Jung · 2015 · Springer eBooks
  65. TEMA 6-2012: REVISIÓN SOBRE LA RELACIÓN DEL GENOTIPO PARA APOE4 Y EL DESARROLLO DE DEMENCIA TIPO ALZHEIMER
    Norbel Román, Carolina Boza-Calvo · 2012
  66. Perspective Developing novel blood-based biomarkers for Alzheimer's disease
    Heather M. Snyder, María C. Carrillo, Francine Grodstein, Kim Henriksen, Andreas Jeromin, Simon Lovestone, Michelle M. Mielke, Lisa J. Bain, Diana W. Shineman, Michael Walter Weiner et al. · 2014
  67. Featured Article Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals
    Ramon Casanova, Sudhir Varma, Brittany N. Simpson, Min Gyu Kim, Yang An, Santiago J. Saldana, Carlos Riveros, Pablo Moscato, Michael E Griswold, Denise Sonntag et al. · 2016
  68. NT-pro BNP as a Blood Biomark- er for Alzheimer's Disease
    Baek Ws, San Bernardino · 2014
  69. Development of Biochip Sensors for Blood Biomarkers Specific to Alzheimer’s Disease Diagnostics
    Suhee Kim, Sang‐Hyuk Lee, Hye Jin Lee · 2017 · Applied Chemistry for Engineering
  70. Genetic polymorphisms in eostrogen and progesterone receptor genes in Papio anubis induced with endometriosis during early stage of the disease
    Irene Mwongeli Waita, Atunga Nyachieo, Daniel C. Chai, Samson Muuo Nzou, Naomi Wangari Maina, Daniel Wainaina Kariuki, Cleophas Mutinda Kyama · 2021 · AIMS molecular science
  71. Characterizing Neurodegenerative Disease Biomarkers in Cerebrospinal Fluid of Non-human Primates
    Emma Robertson · 2021 · QSpace (Queen's University Library)
  72. Endometriosis Research: From Bench to Bedside
    Antonio Simone Laganà, La Rosa, Valentina Lucia · 2022 · MDPI eBooks
  73. Decoding the Epigenome of Neuronal Networks in Health and Disease
    Gaurav Jain · 2019
  74. Proteomics- and Metabolomics-Based Molecular Signatures of Alzheimer's Disease - From Blood to Extracellular Vesicles
    Jonas Ellegaard Nielsen · 2021
  75. Introduction to Pulmonary Diseases and OMICS Approaches
    Sudipto Saha, Sreyashi Majumdar, Parthasarathi Bhattacharyya · 2023 · Springer eBooks
  76. Application of Proteomics in Alzheimer’s Disease: A Mini Review
    Pariveena Sukumaran, Ainun Aida Bahardin, Luqmanul Hakim Abdul Razak, Mohd Harizal Senik · 2023 · Malaysian Journal of Medicine and Health Sciences
  77. Biomarkers for Alzheimer’s Disease
    Mareechika Gaddam, Esther Rani Motamarri, Abha Sharma · 2023 · Springer eBooks
  78. Quantification of Neuroinflammatory Markers in Blood, Cerebrospinal Fluid, and Resected Brain Samples Obtained from Patients
    Arpna Srivastava, Aparna Banerjee Dixit, Manjari Tripathi, Poodipedi Sarat Chandra, Jyotirmoy Banerjee · 2024 · Methods in molecular biology
  79. Additional file 3 of Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer’s disease by meta-analysis and adaptive boosting ensemble learning
    Sze Chung Yuen, Xiaonan Liang, Hongmei Zhu, Yongliang Jia, Siu-wai Leung · 2021 · Figshare
  80. Additional file 2 of Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer’s disease by meta-analysis and adaptive boosting ensemble learning
    Sze Chung Yuen, Xiaonan Liang, Hongmei Zhu, Yongliang Jia, Siu-wai Leung · 2021 · Figshare
  81. Additional file 1 of Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer’s disease by meta-analysis and adaptive boosting ensemble learning
    Sze Chung Yuen, Xiaonan Liang, Hongmei Zhu, Yongliang Jia, Siu-wai Leung · 2021 · Figshare
  82. Endometriosis: A Comprehensive and Concise Review of Potential Biomarkers and Treatment Therapies
    Namra Aziz, Pranay Wal, Chandana Pyne, Shweta Kumari Singh, Sudarshan N. Borkar, Swarnima Pandey, Mukesh Chandra Sharma · 2024 · Current Drug Therapy
  83. Blood-based emerging biomarkers in early detection and diagnosis of Alzheimer’s disease
    Trishna Anand, Awanish Kumar · 2026 · International review of neurobiology
  84. AI-Facilitated Assessment of Cognitive Status Based on Oculomotor Metrics
    Xiaoping Yun, Kyung Koh, Jerry Yu, Yupeng Ren, Li-Qun Zhang · 2026 · ENGINEERING Health & Rehabilitation Engineering
  85. Biomarker and Precision Medicine in Neurology
    Syed Mohammad Nasar Ata, Nitish Kumar Singh, Mayank Gangwar, Jaikee Kumar Singh, Mukesh Kumar · 2026 · Royal Society of Chemistry eBooks